Otitis Media
📧 Sign up to get email alerts when something new happens for Otitis Media.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-03-05FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Amoxicillin and Clavulanate Potassium, a generic antibiotic (…
-
FDA approval · 2009-03-04FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for Clarithromycin from Sandoz Inc, granting approval to a generic version under an ANDA.
-
CLINICAL_TRIALS trial_result · 2009-02-11Clinical Trial Update: Amoxicillin Clavulanate in Treatment of Acute Otitis Media [Phase 4]
A Phase 4 clinical trial update on amoxicillin-clavulanate for treating acute otitis media, with the current status not disclosed.
-
FDA approval · 2009-02-02FDA Approved: AMOXICILLIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for amoxicillin from Teva Pharmaceuticals USA, Inc., resulting in updated labeling and specification…
-
CLINICAL_TRIALS research · 2008-11-19Clinical Trial Update: Observation of Gas Exchange in the Middle Ear
This clinical trial update describes observations of gas exchange in the middle ear, including subjects with normal middle ears and otitis m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children [Phase 3]
Phase 3 trial update reporting safety and efficacy of Floxin Otic Solution for acute otitis media in children; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-03Clinical Trial Update: Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal [Phase 4]
A Phase 4 clinical trial evaluating chlorobutanol, potassium carbonate, and irrigation for cerumen removal has completed, conducted by Hospi…
-
FDA approval · 2008-09-22FDA Approved: CEPHALEXIN — Supplemental Application (AMELLA PHARMA, LLC)
FDA approved a supplemental application for Cephalexin from Amella Pharma, LLC.
-
FDA approval · 2008-09-18FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic ant…
-
FDA approval · 2008-07-23FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cefdinir (CEFDINIR). The approval authorizes changes to the cefdi…
-
FDA approval · 2008-06-16FDA Approved: CEFPODOXIME PROXETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for cefpodoxime proxetil from Aurobindo Pharma Limited, marking a regulatory action on this generic …
-
FDA approval · 2008-06-12FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA has approved a supplemental application for cefdinir (Teva), updating the labeling for the product. This action confirms a labeling-rela…
-
FDA approval · 2008-06-11FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibio…
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media [NA]
A completed clinical trial from the University of Arizona evaluated Echinacea purpurea and osteopathy for preventing recurrent otitis media …
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media [Phase 4]
Phase 4 clinical trial comparing the safety and efficacy of cefdinir oral suspension to azithromycin in pediatric patients with acute otitis…
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media [Phase 2, Phase 3]
Clinical trial update reporting a completed Phase 2/3 study evaluating the safety and efficacy of cefdinir oral suspension for treating acut…
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media [Phase 4]
A Phase 4 clinical trial comparing the safety and efficacy of cefdinir oral suspension to amoxicillin/clavulanate in pediatric acute otitis …
-
FDA approval · 2008-03-10FDA Approved: CEFPROZIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cefprozil from Teva Pharmaceuticals USA, Inc., updating labeling or indications for the anti…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Vaccination for Middle Ear Infection [Phase 1]
Phase 1 trial evaluating a vaccine for otitis media (middle ear infections). The study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Maternal Immunization To Prevent Infant Otitis Media [Phase 1, Phase 2]
Phase 1 and Phase 2 trials of maternal immunization to prevent infant otitis media have completed.
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating Faropenem medoxomil for acute otitis media.
-
FDA approval · 2008-01-16FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental…
-
FDA approval · 2008-01-07FDA Approved: CEFDINIR — Original Application (BluePoint Laboratories)
FDA approves an Abbreviated New Drug Application for cefdinir from BluePoint Laboratories, indicating the availability of a generic cefdinir…
-
FDA approval · 2007-12-14FDA Approved: CEFDINIR — Original Application (Aurobindo Pharma Limited)
FDA approved a generic cefdinir (CEFDINIR) from Aurobindo Pharma Limited under an Original Application (ANDA) for acute otitis media, acute …
-
CLINICAL_TRIALS research · 2007-12-13Clinical Trial Update: PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease [Phase 3]
This clinical trial investigates whether vaccinating Australian Indigenous mothers with a pneumococcal vaccine can prevent ear diseases in t…